TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34211988

Group type: EXPERIMENTAL
Intervention: 308-nm excimer lamp monotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Combination of 308-nm excimer lamp and 10% liquor carbonis detergens
Number of subjects: 30
Study: 35654818

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (no colchicine)
Number of subjects: 240
Study: 35077306

Group type: EXPERIMENTAL
Intervention: Home Group (HG)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Training Group (TG)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 65
Study: 84116008

Group type: EXPERIMENTAL
Intervention: Partial hospitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient hospitalization
Number of subjects: 0
Study: 36162143

Group type: EXPERIMENTAL
Intervention: Functional weightbearing (WB) quadriceps strengthening exercise
Number of subjects: 67

Group type: COMPARATOR
Intervention: Non-weightbearing (NWB) quadriceps strengthening exercise
Number of subjects: 67
Study: 33414533

Group type: EXPERIMENTAL
Intervention: Systemic mycophenolate mofetil (MMF) 1 g orally twice daily for the first 6 months, then 1 g daily for the next 6 months, plus corticosteroids
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Topical 0.03% tacrolimus four times a day for 12 months, plus corticosteroids
Number of subjects: 63

Group type: COMPARATOR
Intervention: Systemic mycophenolate mofetil (MMF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Topical 0.03% tacrolimus
Number of subjects: 63
Study: 35543937

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with regular treatment and swallowing function training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (regular treatment and swallowing function training only)
Number of subjects: 60
Study: 32698033

Group type: EXPERIMENTAL
Intervention: Topical antibiotic ointment
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo (mineral oil and petrolatum‐based) ointment
Number of subjects: 401
Study: 36397221

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Qingfei Qutan decoction
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Qingfei Qutan decoction
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 99
Study: 32293044

Group type: EXPERIMENTAL
Intervention: Cryolipolysis plus low-calorie diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-calorie diet only
Number of subjects: 60
Study: 36402275

Group type: EXPERIMENTAL
Intervention: OUD‐SDM system
Number of subjects: 92
Study: 34002252

Group type: EXPERIMENTAL
Intervention: Once-weekly subcutaneous injection of teriparatide 56.5 μg for 72 weeks
Number of subjects: 1011

Group type: COMPARATOR
Intervention: Monotherapy with alendronate for 120 weeks
Number of subjects: 1011
Study: 32798570

Group type: EXPERIMENTAL
Intervention: HL‐RE
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: cBFR‐RE
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: LL‐RE
Number of subjects: 29
Study: 35974359

Group type: EXPERIMENTAL
Intervention: Gentle heat application with hot water bottles at any sign of illness and onset of fever.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard antipyretic treatment from the participating hospital.
Number of subjects: 24
Study: 32435929

Group type: EXPERIMENTAL
Intervention: ESR eGUIDE
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no ESR eGUIDE)
Number of subjects: 40
Study: 33221636

Group type: EXPERIMENTAL
Intervention: Standardized intervention group (SIG) - brief perioperative smoking cessation intervention with nicotine patch therapy for 8 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care group (UCG) - standard care without the intervention
Number of subjects: 56
Study: 35341647

Group type: EXPERIMENTAL
Intervention: Standard dose (SD, 5x10^10 viral particles)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Low dose (LD, 2.5x10^10 viral particles)
Number of subjects: 422
Study: 33780274

Group type: EXPERIMENTAL
Intervention: Alpelisib 300 mg daily plus fulvestrant 500 mg
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant 500 mg
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Alpelisib
Number of subjects: 341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 341
Study: 32053243

Group type: EXPERIMENTAL
Intervention: Lower BMI
Number of subjects: 224

Group type: COMPARATOR
Intervention: Higher BMI
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Tall participants
Number of subjects: 224
Study: 34603765

Group type: COMPARATOR
Intervention: SAA (Serum Amyloid A) levels
Number of subjects: 75

Group type: COMPARATOR
Intervention: ICAM-1 levels
Number of subjects: 75

Group type: COMPARATOR
Intervention: VCAM-1 levels
Number of subjects: 75

Group type: COMPARATOR
Intervention: sCD27 levels
Number of subjects: 75
Study: 32147925

Group type: EXPERIMENTAL
Intervention: Water-soluble CBD powder (30 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lipid-soluble CBD powder (30 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CBD exposure (both formulations)
Number of subjects: 10
Study: 35579901

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0
Study: 33639578

Group type: EXPERIMENTAL
Intervention: Ingroup associated with high status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingroup associated with low status
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outgroup associated with high status
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outgroup associated with low status
Number of subjects: 0
Study: 32048356

Group type: EXPERIMENTAL
Intervention: CABG with transseptal and transepicardial implantation of CD133+
Number of subjects: 30

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 30
Study: 36028073

Group type: EXPERIMENTAL
Intervention: HIIE-S (Single session of high-intensity interval exercise)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HIIE-D (Two sessions of high-intensity interval exercise 3 hours apart)
Number of subjects: 20
Study: 34060144

Group type: EXPERIMENTAL
Intervention: Low straw (LS, starter feed containing 10% dry matter basis straw; n=11)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Medium straw (MS, starter feed containing 15% dry matter basis straw; n=11)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: High straw (HS, starter feed containing 20% dry matter basis straw; n=11)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (CON, starter without straw; n=11)
Number of subjects: 44
Study: 32652544

Group type: EXPERIMENTAL
Intervention: CZP 200 mg Q2W
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: CZP 400 mg Q2W
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo (followed by CZP 400 mg Q2W escape arm)
Number of subjects: 361
Study: 36432409

Group type: EXPERIMENTAL
Intervention: Fiber supplement
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 131
Study: 34315611

Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 1710

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1710
Study: 34307194

Group type: EXPERIMENTAL
Intervention: Adjunctive COX-2 inhibitor (etoricoxib)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard TB treatment without COX-2 inhibitor
Number of subjects: 39
Study: 32114523

Group type: EXPERIMENTAL
Intervention: Drospirenone 4 mg film-coated tablet, 24 days active treatment followed by 4 days placebo, for 13 cycles of 28 days each
Number of subjects: 21
Study: 34022122

Group type: EXPERIMENTAL
Intervention: Recorded lullabies
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mother's live lullabies
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study: 32522883

Group type: EXPERIMENTAL
Intervention: Equal payment distribution
Number of subjects: 443

Group type: COMPARATOR
Intervention: Unequal payment distribution
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Payment size increase
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 443
Study: 35507959

Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®), n=34
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group, n=31
Number of subjects: 65
Study: 35392886

Group type: EXPERIMENTAL
Intervention: Standardized non-face-to-face primary dental care using the V4H platform
Number of subjects: 368

Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 368
Study: 33630834

Group type: EXPERIMENTAL
Intervention: Genetically decreased vitamin D levels (measured as 25-hydroxyvitamin D, 25OHD)
Number of subjects: 24063

Group type: EXPERIMENTAL
Intervention: Pleiotropy robust MR methods
Number of subjects: 24063

Group type: EXPERIMENTAL
Intervention: Sensitivity analyses excluding SNPs associated with serum lipid levels, body composition, blood traits, and type 2 diabetes
Number of subjects: 24063
Study: 32236329

Group type: EXPERIMENTAL
Intervention: Supervised group (SG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unsupervised group (WG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 35053999

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma Releasate (PRPr)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Corticosteroid (CS)
Number of subjects: 16
Study: 32173637

Group type: EXPERIMENTAL
Intervention: Puerarin combined with naloxone
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 52
Study: 36423240

Group type: EXPERIMENTAL
Intervention: PCC4 (30 units/kg) administered intraoperatively
Number of subjects: 35
Study: 33733688

Group type: EXPERIMENTAL
Intervention: Lung CT Screening Reporting and Data System (Lung‐RADS) categorisation by fellowship-trained thoracic radiologists
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Experienced thoracic radiologists
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Part‐solid risk‐dominant nodules
Number of subjects: 162
Study: 32988371

Group type: EXPERIMENTAL
Intervention: Blended learning (n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Traditional face-to-face approach (n = 24)
Number of subjects: 49
Study: 32797085

Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 8069

Group type: COMPARATOR
Intervention: Color fundus photography (CFP)
Number of subjects: 8069
Study: 34320555

Group type: EXPERIMENTAL
Intervention: In-person clinic visit
Number of subjects: 30

Group type: COMPARATOR
Intervention: Telehealth clinic visit
Number of subjects: 30
Study: 36109167

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 33085551

Group type: EXPERIMENTAL
Intervention: Qualitative research integration into clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Framework for integrating qualitative research
Number of subjects: 0
Study: 35705913

Group type: EXPERIMENTAL
Intervention: Alteplase (rt-PA) for acute ischemic stroke
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sensitivity analyses based on randomization process
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline characteristics and CT results
Number of subjects: 0
Study: 32348263

Group type: EXPERIMENTAL
Intervention: Pedometer app with structured information delivery, personalized physical activity prescription, and follow-up on number of steps per day
Number of subjects: 98

Group type: COMPARATOR
Intervention: Pedometer app with daily walking goal of 10,000 steps
Number of subjects: 98
Study: 36112590

Group type: EXPERIMENTAL
Intervention: Extra virgin coconut oil (EVCO) 25 g
Number of subjects: 20

Group type: COMPARATOR
Intervention: Extra virgin olive oil (EVOO) 25 g
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ad libitum energy intake after EVCO
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ad libitum energy intake after EVOO
Number of subjects: 20
Study: 34075589

Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg intravenous, weeks 0, 4, and 8)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 22
Study: 36197183

Group type: EXPERIMENTAL
Intervention: Moxibustion at 7 to 9 am
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Moxibustion at 5 to 7 pm
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 90
Study: 34425071

Group type: EXPERIMENTAL
Intervention: Selonsertib 2 mg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Selonsertib 6 mg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Selonsertib 18 mg
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 33982167

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using glass ionomer cement (KetacTM Molar Easymix)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 25
Study: 36472135

Group type: EXPERIMENTAL
Intervention: Lower limb loading training (LLLT) with augmented feedback
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lower limb loading training (LLLT) without augmented feedback
Number of subjects: 44
Study: 32166878

Group type: EXPERIMENTAL
Intervention: Brassica juncea feeding for 6 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brassica juncea feeding for 48 hours
Number of subjects: 0
Study: 32071058

Group type: EXPERIMENTAL
Intervention: Presatovir
Number of subjects: 382

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study: 35190503

Group type: EXPERIMENTAL
Intervention: Family Communication Study
Number of subjects: 377
Study: 33639957

Group type: EXPERIMENTAL
Intervention: Fast track surgery (FTS)
Number of subjects: 8886
Study: 34001204

Group type: EXPERIMENTAL
Intervention: Tri-Lock Bone Preservation Stem
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Minima S stem
Number of subjects: 90
Study: 34244749

Group type: EXPERIMENTAL
Intervention: Pharmacological and nonpharmacological interventions (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study: 34657018

Group type: EXPERIMENTAL
Intervention: Biodentine®
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide (CH)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All groups (Biodentine, MTA, CH)
Number of subjects: 50
Study: 32056061

Group type: EXPERIMENTAL
Intervention: Emotion regulation training (8 sessions of 90 minutes each)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 33419872

Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine (PCV9)
Number of subjects: 39836

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39836
Study: 32320007

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioral therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35279300

Group type: EXPERIMENTAL
Intervention: 50% DMSO pretreatment with Single Bond 2 (SB2)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Deionized water with Single Bond 2 (SB2)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: DMSO pretreatment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Bonding steps
Number of subjects: 3
Study: 32039876

Group type: EXPERIMENTAL
Intervention: Real iTBS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 30
Study: 33970042

Group type: EXPERIMENTAL
Intervention: CaneCPI-5 (0.1 mg/mL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: SnCl2/NaF/AmF (Elmex; positive control)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 15
Study: 32046669

Group type: EXPERIMENTAL
Intervention: Online intervention based on Cognitive Behavioral Therapy (n=120)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control (WL, n=120)
Number of subjects: 120
Study: 35346041

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Propofol (PRO)
Number of subjects: 49
Study: 33837097

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) consisting of four online group sessions and online support over 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline phase of 14-28 days before MBI
Number of subjects: 30
Study: 32050198

Group type: EXPERIMENTAL
Intervention: Oxygen-enriched air (FiO2 0.5)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ambient air (FiO2 0.21)
Number of subjects: 20
Study: 32250836

Group type: EXPERIMENTAL
Intervention: Progressive resistance training program (5 sessions/week for 9 weeks)
Number of subjects: 37
Study: 33220397

Group type: EXPERIMENTAL
Intervention: Arm A (AA) with FOLFOX x6 cycles prior to high dose rate brachytherapy (HDRBT) and surgery plus adjuvant FOLFOX x6 cycles
Number of subjects: 180

Group type: COMPARATOR
Intervention: Arm B (AB) with neoadjuvant HDRBT with surgery and adjuvant FOLFOX x12 cycles
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Arm A (AA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Arm B (AB)
Number of subjects: 180
Study: 32941801

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo vaccination
Number of subjects: 198
Study: 36402730

Group type: EXPERIMENTAL
Intervention: Wearable technology (Fitbit Charge 2) with goal setting and text message feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wearable technology alone (active comparator)
Number of subjects: 0
Study: 33499569

Group type: EXPERIMENTAL
Intervention: Fractional carbon dioxide laser combined with autologous fat injection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Laser alone
Number of subjects: 12
Study: 32912292

Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted total hip arthroplasty (RO THA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional manual total hip arthroplasty (CO THA)
Number of subjects: 60
Study: 36214144

Group type: COMPARATOR
Intervention: Basal analgesia: midazolam (1 mg), fentanyl (0.05 mg), dexketoprofen (50 mg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Basal analgesia and nitrous oxide
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Basal analgesia and music
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Basal analgesia, nitrous oxide and music
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients younger than 50 years
Number of subjects: 80
Study: 33415406

Group type: EXPERIMENTAL
Intervention: Psychiatrists experiencing patient suicide
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Trainees experiencing patient suicide
Number of subjects: 324
Study: 32217148

Group type: EXPERIMENTAL
Intervention: Oleoylethanolamide (OEA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 36266163

Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 34246602

Group type: EXPERIMENTAL
Intervention: Early multidomain rehabilitation intervention
Number of subjects: 349
Study: 34022103

Group type: EXPERIMENTAL
Intervention: Lactobacilli (SynForU‐HerCare; two capsules/day of 9·5 log CFU per capsule)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lactobacilli
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 32590220

Group type: EXPERIMENTAL
Intervention: Financial incentive programmes with varying amounts (US$106.19 to $4,027.92)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Comparisons to reduce between-study variations
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Further analyses for non-linear fits and changes in inflection
Number of subjects: 26
Study: 33766837

Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance (NGT) group
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Impaired glucose regulation (IGR) group
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 895
Study: 35527324

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (MMA) protocol including pregabalin, tramadol, wound infiltration, and transversus abdominis plane block
Number of subjects: 97

Group type: COMPARATOR
Intervention: Morphine-based patient-controlled analgesia (PCA)
Number of subjects: 97
Study: 32138501

Group type: EXPERIMENTAL
Intervention: Treprostinil (8‐12 ng/kg·min)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 80
Study: 32566061

Group type: EXPERIMENTAL
Intervention: Orem's self-care model
Number of subjects: 130

Group type: COMPARATOR
Intervention: Traditional care model
Number of subjects: 130
Study: 33461302

Group type: EXPERIMENTAL
Intervention: AT/ET ratio ≥0.32
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: AT/ET ratio >0.32 in patients with low-gradient severe AS
Number of subjects: 1530
Study: 35730409

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34990169

Group type: EXPERIMENTAL
Intervention: Total Worker Health intervention
Number of subjects: 704
Study: 32511707

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 506
Study: 33460466

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Bortezomib
Number of subjects: 136
Study: 35738617

Group type: EXPERIMENTAL
Intervention: Aluminum coated fabric
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Combined aluminum coated fabric with cotton swaddle
Number of subjects: 174

Group type: COMPARATOR
Intervention: Cotton swaddle
Number of subjects: 174
Study: 32170453

Group type: EXPERIMENTAL
Intervention: Single-row fixation (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Double-row fixation (Group II)
Number of subjects: 50
Study: 33769020

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA
Number of subjects: 64

Group type: COMPARATOR
Intervention: OnabotulinumtoxinA
Number of subjects: 64